ARS PHARMACEUTICALS INC

SPRYNASDAQ

🏆 #2994 by market capEarnings Nov 9 · PostUS Equity

$4.31▼ $0.09 (−2.05%)

Market closed · at close

🔔

Track SPRY

Get earnings, price moves & breaking news on Telegram

Track

24h▼ 2.0%

7d▲ 3.6%

14d▲ 3.9%

30d▼ 25.2%

ytd▼ 63.0%

1y▼ 57.3%

🏦Market Cap

$428M

Small Cap

📈Revenue Growth (YoY)

-5.5%

Declining

📊Gross Margin

73.9%

High

💵FCF Margin

-168.1%

Thin

⚖️P/S Ratio

3.7x

Fair

Otter Score

Fair

ARS PHARMACEUTICALS INC

SPRY

Analyst Ratings

Price

$4.31

Total

Raised

Lowered

Avg PT

$20.00

H / L

$25 / $15

Institution	Action	Rating	Date		Upside
Leerink Partners	Reiterated	Outperform	2026-08-13	$15.00	+248.00%
Cantor Fitzgerald	Reiterated	Overweight	2026-05-28	$30.00	+596.10%
Raymond James	Reiterated	Strong Buy	2025-01-14	$32.00	+642.50%
Wedbush	Reiterated	Outperform	2024-03-11	—	—
William Blair	Downgraded	Outperform → Market Perform	2023-09-20	—	—
Goldman Sachs	Downgraded	Buy → Neutral	2022-04-03	—	—
HC Wainwright & Co.	Downgraded	Buy → Neutral	2022-03-31	—	—
Stifel	Downgraded	Buy → Hold	2022-03-31	—	—
JonesTrading	Downgraded	Buy → Hold	2022-03-31	—	—
SVB Leerink	Downgraded	Outperform → Market Perform	2022-03-31	—	—

Institution

Leerink Partners

Reiterated · Outperform · 2026-08-13

$15.00

+248.00%

Cantor Fitzgerald

Reiterated · Overweight · 2026-05-28

$30.00

+596.10%

Raymond James

Reiterated · Strong Buy · 2025-01-14

$32.00

+642.50%

Wedbush

Reiterated · Outperform · 2024-03-11

—

William Blair

Downgraded · Outperform → Market Perform · 2023-09-20

—

Goldman Sachs

Downgraded · Buy → Neutral · 2022-04-03

—

HC Wainwright & Co.

Downgraded · Buy → Neutral · 2022-03-31

—

Stifel

Downgraded · Buy → Hold · 2022-03-31

—

JonesTrading

Downgraded · Buy → Hold · 2022-03-31

—

SVB Leerink

Downgraded · Outperform → Market Perform · 2022-03-31

—

One row per institution · price target from the firm's latest published target

StockOtter · stockotter.space